-
1دورية أكاديمية
المؤلفون: Ryo Saji (11261827), Mototsugu Nishii (11261830), Kazuya Sakai (1816498), Kei Miyakawa (255697), Yutaro Yamaoka (8381508), Tatsuma Ban (11261833), Takeru Abe (336036), Yutaro Ohyama (11261836), Kento Nakajima (10677161), Taro Hiromi (11261839), Reo Matsumura (10677164), Naoya Suzuki (1415311), Hayato Taniguchi (4778331), Tsuyoshi Otsuka (319308), Yasufumi Oi (11261842), Fumihiro Ogawa (764692), Munehito Uchiyama (11261845), Kohei Takahashi (1716979), Masayuki Iwashita (11261848), Yayoi Kimura (1520548), Satoshi Fujii (24755), Ryosuke Furuya (1763764), Tomohiko Tamura (167550), Akihide Ryo (244201), Ichiro Takeuchi (212887)
مصطلحات موضوعية: Medicine, Cell Biology, Molecular Biology, Biotechnology, Immunology, Developmental Biology, Cancer, Infectious Diseases, Virology, Computational Biology, COVID -19. Interleukin, syndrome coronavirus 2, SpO, SARS-CoV -2 RNA, SARS-CoV -2 RNAaemia-based risk str., COVID -19 Background, IL -6, COVID -19 patients, PCR, SARS-CoV -2 RNAaemia, outcome, coronavirus disease 2019, MV, extracorporeal membrane oxygenation, prognostic biomarkers pathophysiolo., ELISA, COVID -19. Methods Clinical, ECMO
-
2صورة
المؤلفون: Ryo Saji (11261827), Mototsugu Nishii (11261830), Kazuya Sakai (1816498), Kei Miyakawa (255697), Yutaro Yamaoka (8381508), Tatsuma Ban (11261833), Takeru Abe (336036), Yutaro Ohyama (11261836), Kento Nakajima (10677161), Taro Hiromi (11261839), Reo Matsumura (10677164), Naoya Suzuki (1415311), Hayato Taniguchi (4778331), Tsuyoshi Otsuka (319308), Yasufumi Oi (11261842), Fumihiro Ogawa (764692), Munehito Uchiyama (11261845), Kohei Takahashi (1716979), Masayuki Iwashita (11261848), Yayoi Kimura (1520548), Satoshi Fujii (24755), Ryosuke Furuya (1763764), Tomohiko Tamura (167550), Akihide Ryo (244201), Ichiro Takeuchi (212887)
مصطلحات موضوعية: Medicine, Cell Biology, Molecular Biology, Biotechnology, Immunology, Developmental Biology, Cancer, Infectious Diseases, Virology, Computational Biology, COVID -19. Interleukin, syndrome coronavirus 2, SpO, SARS-CoV -2 RNA, SARS-CoV -2 RNAaemia-based risk str., COVID -19 Background, IL -6, COVID -19 patients, PCR, SARS-CoV -2 RNAaemia, outcome, coronavirus disease 2019, MV, extracorporeal membrane oxygenation, prognostic biomarkers pathophysiolo., ELISA, COVID -19. Methods Clinical, ECMO
-
3
المؤلفون: Ryo Saji (11261827), Mototsugu Nishii (11261830), Kazuya Sakai (1816498), Kei Miyakawa (255697), Yutaro Yamaoka (8381508), Tatsuma Ban (11261833), Takeru Abe (336036), Yutaro Ohyama (11261836), Kento Nakajima (10677161), Taro Hiromi (11261839), Reo Matsumura (10677164), Naoya Suzuki (1415311), Hayato Taniguchi (4778331), Tsuyoshi Otsuka (319308), Yasufumi Oi (11261842), Fumihiro Ogawa (764692), Munehito Uchiyama (11261845), Kohei Takahashi (1716979), Masayuki Iwashita (11261848), Yayoi Kimura (1520548), Satoshi Fujii (24755), Ryosuke Furuya (1763764), Tomohiko Tamura (167550), Akihide Ryo (244201), Ichiro Takeuchi (212887)
مصطلحات موضوعية: Medicine, Cell Biology, Molecular Biology, Biotechnology, Immunology, Developmental Biology, Cancer, Infectious Diseases, Virology, Computational Biology, COVID -19. Interleukin, syndrome coronavirus 2, SpO, SARS-CoV -2 RNA, SARS-CoV -2 RNAaemia-based risk str., COVID -19 Background, IL -6, COVID -19 patients, PCR, SARS-CoV -2 RNAaemia, outcome, coronavirus disease 2019, MV, extracorporeal membrane oxygenation, prognostic biomarkers pathophysiolo., ELISA, COVID -19. Methods Clinical, ECMO
-
4صورة
المؤلفون: Ryo Saji (11261827), Mototsugu Nishii (11261830), Kazuya Sakai (1816498), Kei Miyakawa (255697), Yutaro Yamaoka (8381508), Tatsuma Ban (11261833), Takeru Abe (336036), Yutaro Ohyama (11261836), Kento Nakajima (10677161), Taro Hiromi (11261839), Reo Matsumura (10677164), Naoya Suzuki (1415311), Hayato Taniguchi (4778331), Tsuyoshi Otsuka (319308), Yasufumi Oi (11261842), Fumihiro Ogawa (764692), Munehito Uchiyama (11261845), Kohei Takahashi (1716979), Masayuki Iwashita (11261848), Yayoi Kimura (1520548), Satoshi Fujii (24755), Ryosuke Furuya (1763764), Tomohiko Tamura (167550), Akihide Ryo (244201), Ichiro Takeuchi (212887)
مصطلحات موضوعية: Medicine, Cell Biology, Molecular Biology, Biotechnology, Immunology, Developmental Biology, Cancer, Infectious Diseases, Virology, Computational Biology, COVID -19. Interleukin, syndrome coronavirus 2, SpO, SARS-CoV -2 RNA, SARS-CoV -2 RNAaemia-based risk str., COVID -19 Background, IL -6, COVID -19 patients, PCR, SARS-CoV -2 RNAaemia, outcome, coronavirus disease 2019, MV, extracorporeal membrane oxygenation, prognostic biomarkers pathophysiolo., ELISA, COVID -19. Methods Clinical, ECMO
-
5
المؤلفون: Ryo Saji (11261827), Mototsugu Nishii (11261830), Kazuya Sakai (1816498), Kei Miyakawa (255697), Yutaro Yamaoka (8381508), Tatsuma Ban (11261833), Takeru Abe (336036), Yutaro Ohyama (11261836), Kento Nakajima (10677161), Taro Hiromi (11261839), Reo Matsumura (10677164), Naoya Suzuki (1415311), Hayato Taniguchi (4778331), Tsuyoshi Otsuka (319308), Yasufumi Oi (11261842), Fumihiro Ogawa (764692), Munehito Uchiyama (11261845), Kohei Takahashi (1716979), Masayuki Iwashita (11261848), Yayoi Kimura (1520548), Satoshi Fujii (24755), Ryosuke Furuya (1763764), Tomohiko Tamura (167550), Akihide Ryo (244201), Ichiro Takeuchi (212887)
مصطلحات موضوعية: Medicine, Cell Biology, Molecular Biology, Biotechnology, Immunology, Developmental Biology, Cancer, Infectious Diseases, Virology, Computational Biology, COVID -19. Interleukin, syndrome coronavirus 2, SpO, SARS-CoV -2 RNA, SARS-CoV -2 RNAaemia-based risk str., COVID -19 Background, IL -6, COVID -19 patients, PCR, SARS-CoV -2 RNAaemia, outcome, coronavirus disease 2019, MV, extracorporeal membrane oxygenation, prognostic biomarkers pathophysiolo., ELISA, COVID -19. Methods Clinical, ECMO